The market for autoimmune diseases therapies is expected to reach US$ 68,410.54 million in 2022 and grow at a moderate rate of 5.6% CAGR over the same period. The market is expected to grow at a value of US$ 1,17,967.44 million by 2032. According to Future Market Insights’ analysis, the historical CAGR was 4.8%. The …